Predicting the course of Alzheimer’s progression
Date
2019-06-17
Journal Title
Journal ISSN
Volume Title
Publisher
SpringerOpen
Abstract
Alzheimer’s disease is the most common neurodegenerative disease and is characterized by the accumulation of
amyloid-beta peptides leading to the formation of plaques and tau protein tangles in brain. These neuropathological
features precede cognitive impairment and Alzheimer’s dementia by many years. To better understand and predict
the course of disease from early-stage asymptomatic to late-stage dementia, it is critical to study the patterns of
progression of multiple markers. In particular, we aim to predict the likely future course of progression for individuals
given only a single observation of their markers. Improved individual-level prediction may lead to improved clinical
care and clinical trials. We propose a two-stage approach to modeling and predicting measures of cognition, function,
brain imaging, fluid biomarkers, and diagnosis of individuals using multiple domains simultaneously. In the first
stage, joint (or multivariate) mixed-effects models are used to simultaneously model multiple markers over time.
In the second stage, random forests are used to predict categorical diagnoses (cognitively normal, mild cognitive
impairment, or dementia) from predictions of continuous markers based on the first-stage model. The combination
of the two models allows one to leverage their key strengths in order to obtain improved accuracy. We characterize
the predictive accuracy of this two-stage approach using data from the Alzheimer’s Disease Neuroimaging Initiative.
The two-stage approach using a single joint mixed-effects model for all continuous outcomes yields better diagnostic
classification accuracy compared to using separate univariate mixed-effects models for each of the continuous
outcomes. Overall prediction accuracy above 80% was achieved over a period of 2.5 years. The results further indicate
that overall accuracy is improved when markers from multiple assessment domains, such as cognition, function, and
brain imaging, are used in the prediction algorithm as compared to the use of markers from a single domain only.
Description
Research Article
Keywords
Alzheimer’s disease, Biomakers, Classification Clinical diagnosis, Disease trajectories, Joint mixed-effects models, Latent time shift, Model averaging, Multi-level Bayesian models, Multi-cohort longitudinal data, Predictions, Random forest